The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $64.62

Today's change-0.90 -1.37%
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $64.62

Today's change-0.90 -1.37%
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.

Express Scripts Holding Co down (U.S.)$0.90

Express Scripts Holding Co closed lower Tuesday, dropping (U.S.)$0.90 or 1.37% to (U.S.)$64.62. Over the last five days, shares have gained 1.89%, but are down 6.06% for the last year to date. Shares have underperformed the S&P 500 by 32.67% during the last year.

Key company metrics

  • Open(U.S.) $65.23
  • Previous close(U.S.) $65.52
  • High(U.S.) $65.78
  • Low(U.S.) $64.58
  • Bid / Ask(U.S.) $61.95 / (U.S.) $66.74
  • YTD % change-6.06%
  • Volume3,475,907
  • Average volume (10-day)5,192,772
  • Average volume (1-month)4,211,081
  • Average volume (3-month)4,816,849
  • 52-week range(U.S.) $57.80 to (U.S.) $80.02
  • Beta0.91
  • Trailing P/E11.69×
  • P/E 1 year forward9.40×
  • Forward PEG0.79×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.53
Updated June 27 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.23%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue24,65524,86325,41025,222
Total other revenue--------
Total revenue24,65524,86325,41025,222
Gross profit1,8732,3382,2742,161
Total cost of revenue22,78222,52523,13623,061
Total operating expense23,60023,38923,99423,966
Selling / general / administrative818864858905
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1,0551,4751,4161,256
Interest income (expense), net non-operating-146-146-273-137
Gain (loss) on sale of assets--------
Other--------
Income before tax9151,3351,1511,130
Income after tax5501,440729727
Income tax, total365-104422403
Net income5461,435723721
Total adjustments to net income--------
Net income before extra. items5461,435723721
Minority interest-4-5-6-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5461,435723721
Inc. avail. to common incl. extra. items5461,435723721
Diluted net income5461,435723721
Dilution adjustment--------
Diluted weighted average shares605613627636
Diluted EPS excluding extraordinary itemsvalue per share0.902.341.151.13
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.902.341.151.13